Text Size

Biodegradable intraocular therapies for retinal disorders: Progress to date

Kuno N., Fujii S.


  • 2010
  • Drugs and Aging
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology

    Drug Delivery

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co. Ltd, 8916-16, Takayama-cho, Ikoma-shi, Nara 630-0101, Japan

Related Publications

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D


Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.


Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction

Sharif, N.A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022